Drug Shortage Report for MYLAN-GLICLAZIDE MR
Report ID | 224058 |
Drug Identification Number | 02438658 |
Brand name | MYLAN-GLICLAZIDE MR |
Common or Proper name | GLICLAZIDE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | GLICLAZIDE |
Strength(s) | 30MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100BT |
ATC code | A10BB |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2024-03-21 |
Estimated end date | 2024-08-14 |
Actual end date | 2024-08-15 |
Shortage status | Resolved |
Updated date | 2024-08-20 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v20 | 2024-08-20 | French | Compare |
v19 | 2024-08-20 | English | Compare |
v18 | 2024-08-12 | French | Compare |
v17 | 2024-08-12 | English | Compare |
v16 | 2024-07-29 | French | Compare |
v15 | 2024-07-29 | English | Compare |
v14 | 2024-07-16 | French | Compare |
v13 | 2024-07-16 | English | Compare |
v12 | 2024-07-09 | French | Compare |
v11 | 2024-07-09 | English | Compare |
v10 | 2024-07-03 | French | Compare |
v9 | 2024-07-03 | English | Compare |
v8 | 2024-05-17 | French | Compare |
v7 | 2024-05-17 | English | Compare |
v6 | 2024-04-16 | French | Compare |
v5 | 2024-04-16 | English | Compare |
v4 | 2024-04-09 | French | Compare |
v3 | 2024-04-09 | English | Compare |
v2 | 2024-04-01 | French | Compare |
v1 | 2024-04-01 | English | Compare |
Showing 1 to 20 of 20